Kits Eyecare (KITS) Stock Price, News & Analysis

Company Overview

KITS (TSX: KITS) is one of the world's fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.

Key Stats

• Today's Range: C$15.16 to C$15.46
• 50-Day Range: C$12.48 to C$15.29
• 52-Week Range: C$10.61 to C$22.56
• Volume: 54,189 shs
• Average Volume: 116,019 shs
• Market Capitalization: C$517.23 million
• P/E Ratio: 95.06
• Dividend Yield: N/A
• Price Target: C$20.69
• Consensus Rating: Buy

Kits Eyecare Stock Analysis - MarketRank™

Kits Eyecare scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Kits Eyecare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 4 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Kits Eyecare has a consensus price target of C$20.69, representing about 36.0% upside from its current price of C$15.21.

Amount of Analyst Coverage

Kits Eyecare has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Kits Eyecare is 95.06, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 45.35.

Price to Earnings Ratio vs. Sector

The P/E ratio of Kits Eyecare is 95.06, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 46.75.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for KITS.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Kits Eyecare does not currently pay a dividend.

Dividend Growth

Kits Eyecare does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Kits Eyecare this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Kits Eyecare insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$1,023,750.00 in company stock.

Percentage Held by Institutions

14.63% of the stock of Kits Eyecare is held by institutions.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 8/21/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Consumer Discretionary
• Industry: Specialty Retail
• Sub-Industry: Other Specialty Retail
• Current Symbol: TSE:KITS
• CIK: N/A
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Kits Eyecare: C$20.69
• High Price Target: C$23.00
• Low Price Target: C$16.75
• Potential Upside/Downside: +36.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 95.06
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$222.18 million
• Price / Sales: 2.33
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 34,006,000
• Free Float: N/A
• Market Cap: C$517.23 million
• Optionable: N/A
• Beta: 0.06